These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10356019)

  • 1. Economic Notes: opportunity cost.
    Palmer S; Raftery J
    BMJ; 1999 Jun; 318(7197):1551-2. PubMed ID: 10356019
    [No Abstract]   [Full Text] [Related]  

  • 2. When Opportunity Knocks, What Does It Say?
    Phelps CE
    Value Health; 2019 Aug; 22(8):851-853. PubMed ID: 31426924
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis without treatment as a modifier in health economic assessments.
    Camidge R; Walker A; Oliver JJ; Nussey F; Maxwell S; Jodrell D; Webb DJ
    BMJ; 2005 Jun; 330(7504):1382-4. PubMed ID: 15947403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 5. Economics, QALYs and medical ethics: a practical agenda?
    Robinson R
    Health Care Anal; 1995 Aug; 3(3):229-32. PubMed ID: 10151643
    [No Abstract]   [Full Text] [Related]  

  • 6. The DH register of cost-effectiveness studies: content and quality.
    Mason J; Drummond M
    Health Trends; 1995; 27(2):50-6. PubMed ID: 10153159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economics, QALYs and medical ethics--a health economist's perspective.
    Williams A
    Health Care Anal; 1995 Aug; 3(3):221-6. PubMed ID: 10151641
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of NICE's recommendations, 1999-2005.
    Raftery J
    BMJ; 2006 May; 332(7552):1266-8. PubMed ID: 16735341
    [No Abstract]   [Full Text] [Related]  

  • 9. Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.
    Steinbrook R
    N Engl J Med; 2008 Nov; 359(19):1977-81. PubMed ID: 18987366
    [No Abstract]   [Full Text] [Related]  

  • 10. How much are Americans willing to pay for a quality-adjusted life year?
    Weinstein MC
    Med Care; 2008 Apr; 46(4):343-5. PubMed ID: 18362811
    [No Abstract]   [Full Text] [Related]  

  • 11. How NICE may be outflanked.
    Ferner RE; McDowell SE
    BMJ; 2006 May; 332(7552):1268-71. PubMed ID: 16735342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Economic evaluation within the scope of clinical studies].
    Walshe R; Diehl V
    Internist (Berl); 1998 Sep; 39(9):943-54. PubMed ID: 9788116
    [No Abstract]   [Full Text] [Related]  

  • 13. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 14. QALYs: maximisation, distribution and consent. A response to Alan Williams.
    Menzel PT
    Health Care Anal; 1995 Aug; 3(3):226-9. PubMed ID: 10151642
    [No Abstract]   [Full Text] [Related]  

  • 15. Should we aggregate relative or absolute changes in QALYs?
    Johannesson M
    Health Econ; 2001 Oct; 10(7):573-7. PubMed ID: 11747040
    [No Abstract]   [Full Text] [Related]  

  • 16. Lenalidomide for the treatment of relapsed multiple myeloma.
    Gajraj E; Chung H; Boysen M; Barnett DB; Longson C
    Lancet Oncol; 2009 Jul; 10(7):647-8. PubMed ID: 19585686
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward a broader view of values in cost-effectiveness analysis of health.
    Menzel P; Gold MR; Nord E; Pinto-Prades JL; Richardson J; Ubel P
    Hastings Cent Rep; 1999; 29(3):7-15. PubMed ID: 10420299
    [No Abstract]   [Full Text] [Related]  

  • 18. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
    Higgins AM; Harris AH
    Crit Care Clin; 2012 Jan; 28(1):11-24, v. PubMed ID: 22123096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A NICE fallacy.
    Quigley M
    J Med Ethics; 2007 Aug; 33(8):465-6. PubMed ID: 17664304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A note on cost-value analysis.
    Østerdal LP
    Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.